Description: The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Innovation Labs Cannabis Index. The fund will invest at least 80% of its total assets in the component securities of the index. It will also invest, under normal circumstances, at least 80% of its net assets, plus borrowings for investment purposes, in exchange listed common stock (or corresponding American Depositary Receipts (ADRs) of Cannabis Companies. The index is a proprietary, rules-based index designed to track the performance of a portfolio of Cannabis Companies. The fund is non-diversified.
Exchange: NYSE ARCA
Country: US
Currency: US Dollar ($)
Category: Miscellaneous Sector
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock non-US | 52.22 | 0.00 | 52.22 |
| Stock US | 45.78 | 0.00 | 45.78 |
| Cash | 2.00 | 0.00 | 2.00 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 67.46 | 6.23 |
| Basic Materials | 9.40 | 4.69 |
| Real Estate | 6.17 | 1.65 |
| Consumer Defensive | 5.72 | 0.53 |
| Technology | 4.97 | 36.56 |
| Consumer Cyclicals | 3.23 | 6.90 |
| Industrials | 3.04 | 22.73 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 100.00 | 62.43 |
| Japan | 0.00 | 4.59 |
| Australasia | 0.00 | 1.06 |
| Asia Emerging | 0.00 | 8.60 |
| Latin America | 0.00 | 2.38 |
| Asia Developed | 0.00 | 3.23 |
| United Kingdom | 0.00 | 2.07 |
| Europe Emerging | 0.00 | 0.40 |
| Europe Developed | 0.00 | 14.38 |
| Africa/Middle East | 0.00 | 0.87 |